Effects of cyclosporine and α-difluoromethylornithine on the growth of mouse colon cancer in vitro

Rami Saydjari, Courtney Townsend, Sam C. Barranco

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The growth and survival of mouse (MC-26) colon carcinoma in vitro and in vivo are significantly reduced by inhibitors of polyamine biosynthesis. α-Difluoromethylornithine (DFMO), is a specific and irreversible inhibitor of ornithine decarboxylase (ODC); the rate-limiting enzyme in polyamine biosynthesis. DFMO treatment inhibits the growth of MC-26 colon cancer cells and decreases MC-26 cell survival both in vitro and in vivo. In the present study, we examined the effects of cyclosporine (CsA) on growth, survival, and effects on MC-26 colon cancer growth which were similar to DFMO; these effects were blocked by the addition of the polyamine, putrescine. The combination of CsA (8.3×10-4 mM) and DFMO (0.5 mM or 1.0 mM) inhibited MC-26 cell survival to a greater extent than either agent alone. These results suggest that CsA given in combination with other agents which inhibit polyamine synthesis may be useful for the treatment of colon cancer.

Original languageEnglish (US)
Pages (from-to)359-366
Number of pages8
JournalLife Sciences
Volume40
Issue number4
DOIs
StatePublished - Jan 26 1987

Fingerprint

Eflornithine
Polyamines
Colonic Neoplasms
Cyclosporine
Biosynthesis
Cells
Growth
Cell Survival
Putrescine
Colon
Carcinoma
In Vitro Techniques
Enzymes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of cyclosporine and α-difluoromethylornithine on the growth of mouse colon cancer in vitro. / Saydjari, Rami; Townsend, Courtney; Barranco, Sam C.

In: Life Sciences, Vol. 40, No. 4, 26.01.1987, p. 359-366.

Research output: Contribution to journalArticle

@article{26b53b4eaa58449a987326f309339a8e,
title = "Effects of cyclosporine and α-difluoromethylornithine on the growth of mouse colon cancer in vitro",
abstract = "The growth and survival of mouse (MC-26) colon carcinoma in vitro and in vivo are significantly reduced by inhibitors of polyamine biosynthesis. α-Difluoromethylornithine (DFMO), is a specific and irreversible inhibitor of ornithine decarboxylase (ODC); the rate-limiting enzyme in polyamine biosynthesis. DFMO treatment inhibits the growth of MC-26 colon cancer cells and decreases MC-26 cell survival both in vitro and in vivo. In the present study, we examined the effects of cyclosporine (CsA) on growth, survival, and effects on MC-26 colon cancer growth which were similar to DFMO; these effects were blocked by the addition of the polyamine, putrescine. The combination of CsA (8.3×10-4 mM) and DFMO (0.5 mM or 1.0 mM) inhibited MC-26 cell survival to a greater extent than either agent alone. These results suggest that CsA given in combination with other agents which inhibit polyamine synthesis may be useful for the treatment of colon cancer.",
author = "Rami Saydjari and Courtney Townsend and Barranco, {Sam C.}",
year = "1987",
month = "1",
day = "26",
doi = "10.1016/0024-3205(87)90137-8",
language = "English (US)",
volume = "40",
pages = "359--366",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of cyclosporine and α-difluoromethylornithine on the growth of mouse colon cancer in vitro

AU - Saydjari, Rami

AU - Townsend, Courtney

AU - Barranco, Sam C.

PY - 1987/1/26

Y1 - 1987/1/26

N2 - The growth and survival of mouse (MC-26) colon carcinoma in vitro and in vivo are significantly reduced by inhibitors of polyamine biosynthesis. α-Difluoromethylornithine (DFMO), is a specific and irreversible inhibitor of ornithine decarboxylase (ODC); the rate-limiting enzyme in polyamine biosynthesis. DFMO treatment inhibits the growth of MC-26 colon cancer cells and decreases MC-26 cell survival both in vitro and in vivo. In the present study, we examined the effects of cyclosporine (CsA) on growth, survival, and effects on MC-26 colon cancer growth which were similar to DFMO; these effects were blocked by the addition of the polyamine, putrescine. The combination of CsA (8.3×10-4 mM) and DFMO (0.5 mM or 1.0 mM) inhibited MC-26 cell survival to a greater extent than either agent alone. These results suggest that CsA given in combination with other agents which inhibit polyamine synthesis may be useful for the treatment of colon cancer.

AB - The growth and survival of mouse (MC-26) colon carcinoma in vitro and in vivo are significantly reduced by inhibitors of polyamine biosynthesis. α-Difluoromethylornithine (DFMO), is a specific and irreversible inhibitor of ornithine decarboxylase (ODC); the rate-limiting enzyme in polyamine biosynthesis. DFMO treatment inhibits the growth of MC-26 colon cancer cells and decreases MC-26 cell survival both in vitro and in vivo. In the present study, we examined the effects of cyclosporine (CsA) on growth, survival, and effects on MC-26 colon cancer growth which were similar to DFMO; these effects were blocked by the addition of the polyamine, putrescine. The combination of CsA (8.3×10-4 mM) and DFMO (0.5 mM or 1.0 mM) inhibited MC-26 cell survival to a greater extent than either agent alone. These results suggest that CsA given in combination with other agents which inhibit polyamine synthesis may be useful for the treatment of colon cancer.

UR - http://www.scopus.com/inward/record.url?scp=0023665432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023665432&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(87)90137-8

DO - 10.1016/0024-3205(87)90137-8

M3 - Article

C2 - 3100897

AN - SCOPUS:0023665432

VL - 40

SP - 359

EP - 366

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 4

ER -